From the “AI Pilot Graveyard” to Enterprise- Grade Impact
Accelerating Cross-Sector Integration in Pharma and Nutraceuticals
Early-Phase Oncology Trials Shaping the Future of Cancer Research
Cloud-Native Drug Discovery
Controlling Polysorbate Degradation
EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
Compliance to Competitive Advantage in Pharma Supply
Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser
Advisory Board
.webp)
KNOWLEDGE BANK
-
Articles
Role of Excipients in Drug Formulation: Functions, Types, and Applications
Whenever we consider medicines we tend to immediately jump into thinking about the active pharmaceutical ingredients APIs the substances that have therapeutic effects However APIs are not enough to develop stable effective and patientfriendly medicines This is where pharmaceutical excipients would come in The importance of excipients in the case of pharmaceuticals can go well beyond the level
Lessons from Technology Transfer in Global Drug Product Development: From Knowledge Transfer to Commercial Success
Technology transfer is the critical bridge between pharmaceutical development and commercial manufacturing transforming scientific innovation into medicines that can be reliably produced at scale Successful technology transfer extends far beyond the transfer of manufacturing processes and documentation
7 B2B Pharma Display Ad Strategies That Actually Drive Leads (2026 Guide)
Theres a quiet frustration most pharma marketers dont say out loud display ads should work better than they do Budgets go in Impressions look fine CTRs are acceptable And yet pipeline barely moves
Combination Immunotherapy Trials: Designing the Next Generation of Cancer Drugs
For most of the past ten years the prevailing strategy in immunooncology was addition Checkpoint blockade delivered durable remissions in a minority of patients the intuitive fix was to attach a second agent to a PD or PDL backbone and watch whether response rates moved
From Visibility to Decision Readiness: The Next Phase of Quality Maturity in Pharma
Over the past decade pharmaceutical organisations have made strong progress in both digitising and digitalising quality operations Systems such as laboratory information management systems LIMS manufacturing execution systems MES and electronic quality management systems eQMS have strengthened traceability embedded workflows and enabled real time visibility across quality processes
Pharma Safety in Sterile Fill-Finish: Ensuring Quality and Compliance
The sterile fillfinish process is the final step in pharmaceutical manufacturing before medications reach patients This process is particularly critical for injectable drugs because they bypass the bodys natural defense mechanisms
-
Techno Trends
Alume Biosciences Secures FDA Breakthrough Therapy Designation for Bevonescein
Alume Biosciences has received Breakthrough Therapy Designation BTD from the US Food and Drug Administration FDA for bevonescein an investigational fluorescent drug being developed to support realtime nerve visualisation during head and neck surgery in adults Bevonescein is an intravenous fluorescent peptidedye conjugate that binds to nerve tissue
-
Projects
SK pharmteco Plans More Than US$200 Million Investment in Small Molecule and Peptide Manufacturing
SK pharmteco is planning a fiveyear investment of more than US million to expand and modernise its pharmaceutical development and manufacturing operations in the United States The programme will strengthen capabilities for small molecules and peptides while supporting a more
-
Research Insights
A drug repurposing screen reveals dopamine signaling as a candidate therapeutic pathway for PIGA-CDG
PIGACDG is a congenital disorder of glycosylation caused by pathogenic partial lossoffunction variants in the PIGA gene PIGA encodes an enzyme responsible for the catalytic transfer of Nacetylglucosamine
-
whitepaper
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys
TOP ARTICLES
-
1
Lessons from Technology Transfer in Global Drug Product Development: From Knowledge Transfer to Commercial Success
Dr. Shashi Ravi Suman Rudrangi
Technology transfer is more than transferring manufacturing processes between sites. Commercial success depends on preserving scientific understanding, organisational knowledge and cross-functional co...
-
2
7 B2B Pharma Display Ad Strategies That Actually Drive Leads (2026 Guide)
Kate Williamson
This article discusses seven effective B2B pharma display advertisement techniques which go beyond the impressions to make real leads. It emphasizes the significance of tight targeting, account-based...
-
3
Combination Immunotherapy Trials: Designing the Next Generation of Cancer Drugs
Lakshmi
Combination immunotherapy is now a portfolio necessity, yet late-stage combination trials in oncology continue to fail at an uncomfortable rate. This article examines why attaching a second immune tar...
-
4
From Visibility to Decision Readiness: The Next Phase of Quality Maturity in Pharma
Kavita Vengurlekar
Pharma companies can now see quality issues much earlier, thanks to digital systems. But faster visibility hasn’t always meant faster decisions. This article explains why the next step in qualit...
-
5
Pharma Safety in Sterile Fill-Finish: Ensuring Quality and Compliance
Kate Williamson
This comprehensive overview explores the critical aspects of ensuring safety and compliance in sterile fill-finish operations within the pharmaceutical industry. It discusses regulatory requirements,...
press releases Read more...
Enveda Collaborates with Anthropic to Accelerate Drug Development
Enveda a biotechnology company using AI to translate natures chemistry into new medicines today announced results from its collaboration with Anthropic to streamline critical documentation processes in drug development Working with Claude Enveda developed AIenabled workflows to review Good Manufactu...
Pythia Labs Launches with AI-Designed Antibodies for Hard-to-Drug Targets
Pythia Labs a biotechnology company building frontier AI models for therapeutic discovery today announced its launch alongside a preprint in bioRxiv introducing Pythia the allatom generative model at the core of its antibody design platform Pythias technology is built to create antibodies against ta...
Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
Genmab AS and Incyte announced a clinical trial collaboration to evaluate petosemtamab Genmabs investigational IgGbispecific antibody targeting the epidermal growth factor receptor EGFR and leucinerich repeat containing Gproteincoupled receptor LGR in combination with INCB Incytes investigational p...
CasZyme and Cirena to Collaborate on Developing Longer Guide RNAs to Optimise Cas12l Performance
CasZyme and Cirena have today signed an agreement that will see the two companies collaborate on further optimising the editing efficiency of CasZymes Casl CRISPR nuclease in humanrelevant applications using Cirenas synthetic nt guide RNAs
Events Read more...
28 - 30
Oct 2026BIOPLUS-INTERPHEX KOREA 2026
COEX, Seoul
02 - 04
Nov 2026Pharma Forum EMEA 2026
Dom Pedro Lisboa Hotel, Lisbon...
02 - 04
Nov 2026Cancer R&D 2026
Houston, TX, USA
03 - 05
Nov 202610th Dermatology Drug Development
Boston, Massachusetts at The C...
03 - 04
Nov 2026PDA Aseptic Processing of Biopharma Conference
Sheraton Grand Incheon Hotel,...
04 - 05
Nov 2026Advanced Therapies USA
Hynes Convention Center, Bosto...
05 - 05
Nov 2026PDA Contamination Control Strategy Workshop
Sheraton Grand Incheon Hotel,...
09 - 11
Nov 202611th Microbiome Movement USA Summit
The Colonnade Hotel, Boston, M...
LATEST NEWS Read more...
Roche strengthens cancer diagnostic portfolio with launch of test for differential diagnosis of mesothelioma
Roche announced today the global launch of the VENTANA BAP SP test This automated readytouse immunohistochemistry IHC assay provides a reliable highly specific diagnostic tool to help clinicians and pathologists accurately identify mesothelioma and distinguish it from other malignancies including no...
Stevanato Group and Aptar Pharma Collaborate to Help Accelerate Pre-Filled Syringe System Selection
Stevanato Group SpA a leading global provider of drug containment drug delivery and diagnostic solutions to the pharmaceutical biotechnology and life sciences industries today announced a collaboration with Aptar Pharma to provide systemlevel data supporting earlier evaluation of prefilled syringe c...
Sacituzumab Tirumotecan (Sac-TMT) Reduced the Risk of Death by 32% and the Risk of Disease Progression or Death by 41% Compared to Chemotherapy in Patients With Recurrent Endometrial Cancer
Merck known as MSD outside of the United States and Canada today announced the first presentation of results from the pivotal Phase TroFuse trial evaluating sacituzumab tirumotecan sacTMT an investigational TROPdirected antibodydrug conjugate ADC being developed in collaboration with KelunBiotech i...
Tempus Receives IVDR Certification for xR RNA Sequencing for Solid Tumor Profiling
Tempus AI Inc announced that its xR assay has received certification under the European Unions In Vitro Diagnostic Regulation IVDR as a Class C in vitro diagnostic device The certification covers Tempus quality management system for nextgeneration sequencing devices for cancer genomic profiling to s...
Georgiamune and Menarini Group Enter Exclusive Global License and Collaboration Agreement for GIM-621, a First-in-Class Oral Immuno-Oncology Agent
The Menarini Group a leading international pharmaceutical and diagnostics company and Stemline Therapeutics Inc Stemline a whollyowned subsidiary of the Menarini Group focused on bringing transformational oncology treatments to cancer patients along with Georgiamune Inc a clinicalstage biotechnology...
LGM Pharma Acquires Sannova Analytical, Expanding cGMP Analytical and GLP Bioanalytical Services
LGM Pharma a leading provider of tailored API sourcing contract analytical testing and drug development services today announced it has acquired Sannova Analytical a contract research laboratory headquartered in Somerset NJ The acquisition expands LGM Pharmas analytical testing services business by...
